GMXRX
Price
$16.39
Change
-$0.28 (-1.68%)
Updated
Jul 29 closing price
Net Assets
476.82M
VIMAX
Price
$399.42
Change
-$3.56 (-0.88%)
Updated
Jul 29 closing price
Net Assets
223.97B
Interact to see
Advertisement

GMXRX vs VIMAX

GMXRX vs VIMAX Comparison Chart in %
View a ticker or compare two or three
VS
GMXRX vs. VIMAX commentary
Jul 31, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMXRX is a Buy and VIMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 224B vs. GMXRX (477M). VIMAX pays higher dividends than GMXRX: VIMAX (1.31) vs GMXRX (0.39). GMXRX was incepted earlier than VIMAX: GMXRX (19 years) vs VIMAX (25 years). GMXRX (1.03) is less costly to investors than VIMAX (0.05). VIMAX (16.00) and GMXRX (15.69) have comparable annual turnover. GMXRX has a lower initial minimum investment than VIMAX: GMXRX (0) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 13.16 vs. GMXRX (4.00). VIMAX return over 5 years is better than : 36.62 vs. GMXRX (-12.21).
GMXRXVIMAXGMXRX / VIMAX
Total Expense Ratio1.000.052,000%
Annual Report Gross Expense Ratio1.030.052,060%
Fund Existence19 years25 years-
Gain YTD13.22312.222108%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets477M224B0%
Annual Yield % from dividends0.391.3130%
Returns for 1 year4.0013.1630%
Returns for 3 years5.4444.3212%
Returns for 5 years-12.2136.62-33%
Returns for 10 years-0.82156.78-1%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYOIX88.91N/A
N/A
Rydex Biotechnology Inv
CMNWX88.93N/A
N/A
Principal Capital Appreciation A
MFWTX18.52N/A
N/A
MFS Global Total Return A
TEIHX51.42N/A
N/A
Nuveen Equity Index I
GSAJX20.50N/A
N/A
Goldman Sachs Small Cap Growth Instl